Tomohisa Nakada

414 total citations
14 papers, 337 citations indexed

About

Tomohisa Nakada is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tomohisa Nakada has authored 14 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pharmacology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Tomohisa Nakada's work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Tomohisa Nakada is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Tomohisa Nakada collaborates with scholars based in Japan and United States. Tomohisa Nakada's co-authors include Hiroyuki Kusuhara, Hisao Nemoto, Toshiyuki Kudo, Yoshinori Yamamoto, Kazuya Maeda, Takashi Yoshikado, Kiyomi Ito, Toshiyuki Kume, Y Sugiyama and Kenta Yoshida and has published in prestigious journals such as Journal of the American Chemical Society, British Journal of Pharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Tomohisa Nakada

14 papers receiving 333 citations

Peers

Countries citing papers authored by Tomohisa Nakada

Since Specialization

Citations

This map shows the geographic impact of Tomohisa Nakada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohisa Nakada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohisa Nakada more than expected).

Fields of papers citing papers by Tomohisa Nakada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohisa Nakada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohisa Nakada. The network helps show where Tomohisa Nakada may publish in the future.

Co-authorship network of co-authors of Tomohisa Nakada

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohisa Nakada. A scholar is included among the top collaborators of Tomohisa Nakada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohisa Nakada. Tomohisa Nakada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Insights into drug development with quantitative systems pharmacology: A prospective case study of uncovering hyperkalemia risk in diabetic nephropathy with virtual clinical trials 2024 ·Drug Metabolism and Pharmacokinetics ·(unknown), Tomohisa Nakada	1
2	Quantitative Consideration of Clinical Increases in Serum Creatinine Caused by Renal Transporter Inhibition 2023 ·Drug Metabolism and Disposition ·Tomohisa Nakada, Toshiyuki Kudo, (unknown)	14
3	Systems model identifies baseline cytokine concentrations as potential predictors of rheumatoid arthritis inflammatory response to biologics 2022 ·British Journal of Pharmacology ·Tomohisa Nakada, Donald E. Mager	7
4	Prediction of human pharmacokinetics for low‐clearance compounds using pharmacokinetic data from chimeric mice with humanized livers 2021 ·Clinical and Translational Science ·Kosuke Yoshida, (unknown), (unknown), Hidenori Yasuhara, Yuka Ikenaga, H. Shimizu, Tomohisa Nakada, Tomoko Watanabe, Chise Tateno, Seigo Sanoh, Yaichiro Kotake	5
5	Mechanistic evaluation of the effect of sodium‐dependent glucose transporter 2 inhibitors on delayed glucose absorption in patients with type 2 diabetes mellitus using a quantitative systems pharmacology model of human systemic glucose dynamics 2020 ·Biopharmaceutics & Drug Disposition ·(unknown), (unknown), Tomohisa Nakada, Yoshinobu Nakamaru, (unknown), (unknown)	7
6	Estimation of changes in serum creatinine and creatinine clearance caused by renal transporter inhibition in healthy subjects 2019 ·Drug Metabolism and Pharmacokinetics ·Tomohisa Nakada, Toshiyuki Kudo, Toshiyuki Kume, Hiroyuki Kusuhara, Kiyomi Ito	37
7	Prediction of Human Distribution Volumes of Compounds in Various Elimination Phases Using Physiologically Based Pharmacokinetic Modeling and Experimental Pharmacokinetics in Animals 2018 ·Drug Metabolism and Disposition ·H. Shimizu, Kosuke Yoshida, Tomohisa Nakada, (unknown), (unknown), Yoshinobu Nakamaru, Hiroshi Yamazaki	17
8	Quantitative analysis of elevation of serum creatinine via renal transporter inhibition by trimethoprim in healthy subjects using physiologically-based pharmacokinetic model 2017 ·Drug Metabolism and Pharmacokinetics ·Tomohisa Nakada, Toshiyuki Kudo, Toshiyuki Kume, Hiroyuki Kusuhara, Kiyomi Ito	23
9	Comparison of Methods for Estimating Unbound Intracellular-to-Medium Concentration Ratios in Rat and Human Hepatocytes Using Statins 2017 ·Drug Metabolism and Disposition ·Takashi Yoshikado, Kota Toshimoto, Tomohisa Nakada, (unknown), Hiroyuki Kusuhara, Kazuya Maeda, Yuichi Sugiyama	44
10	Quantitative Analyses of Hepatic OATP‐Mediated Interactions Between Statins and Inhibitors Using PBPK Modeling With a Parameter Optimization Method 2016 ·Clinical Pharmacology & Therapeutics ·Takashi Yoshikado, Kenta Yoshida, Naoki Kotani, Tomohisa Nakada, (unknown), (unknown), Kazuya Maeda, Hiroyuki Kusuhara, Y Sugiyama	84
11	Evaluation of the Potency of Telaprevir and Its Metabolites as Inhibitors of Renal Organic Cation Transporters, a Potential Mechanism for the Elevation of Serum Creatinine 2013 ·Drug Metabolism and Pharmacokinetics ·Tomohisa Nakada, (unknown), Katsuhisa Inoue, Satohiro Masuda, Ken‐ichi Inui, Kazuo Matsubara, Yoshinori Moriyama, (unknown), Yasuhisa Adachi, Masayuki Suzuki, I. Yamada, Hiroyuki Kusuhara	7
12	Lung tumorigenesis promoted by anti-apoptotic effects of cotinine, a nicotine metabolite through activation of PI3K/Akt pathway 2012 ·The Journal of Toxicological Sciences ·Tomohisa Nakada, Kazuma Kiyotani, Shunsuke Iwano, (unknown), Masanao Yokohira, Keiko Yamakawa, Masaki Fujieda, Tetsuya Saito, Hiroshi Yamazaki, Katsumi Imaida, Tetsuya Kamataki	36
13	NMR detection of N-acyliminium ion intermediates generated from .alpha.-alkoxycarbamates 1992 ·Journal of the American Chemical Society ·Yoshinori Yamamoto, Tomohisa Nakada, Hisao Nemoto	50
14	Production of viomycin-like substance by a Streptomyces. 1957 ·PubMed ·Tadashi Arai, Tomohisa Nakada, Masaaki Suzuki	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact